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Biological Monitoring
Biological monitoring is used to measure industrial chemicals, etc.) by immunoassay has been used for about 35 years and was initiated in 1917(1). Immunoassays are now being developed to detect environmental contaminants found in the excreta and tissues as parent chemical, metabolites, and adducts (Table 1 ). The major advantages ofthe immunoassay method for performing this environmental biomonitoring are sensitivity, specificity for the analyte, simplicity and speed of analyses for multiple samples, and ease of standardization.
Immunochemistry Defliitions
Antigens are substances that are recognized by the immune system as foreign to the host and induce an immune response. An immune response may or may not involve the production of soluble antibodies (some immune responses are cell mediated). The part of the antigen to which the antibody binds is the antigenic determinant or epitope. Antigens have many different potential determinants, such as various portions of a bacterial cell wall.
Antibodies are a class of proteins that are induced following introduction ofan antigen. Because these proteins are found in the gamma globulin fraction of serum, the term "immunoglobulins" (Ig) is synonymous for antibodies. There are five main classes ofantibodies: IgG, IgM, IgA, IgD, and IgE. IgG is the major class of serum immunoglobulins. IgG antibodies have a molecular weight of about 150,000 and possess four peptide chains: two identical heavy chains (MW 50,000) and two identical light chains (MW 25,000). IgM is the first class ofantibody produced during the primary response. It is a pentamer of the basic IgG antibody structure, which itselfcontains two combining sites, or paratopes. These paratopes are the sites ofantibody interaction with the antigen and are of equal affinity and specificity for the determinant ofthe antigen. This region ofthe immunoglobulin molecule is called the variable region.
IgG constitutes most of the secondary response to antigens. Because ofthis, most immunoassays use IgG antibodies. IgM has ten identical variable regions. Immunologists estimate that over 11 million variable regions are possible (2) . This diversity is exploited in antigen-directed immunoassays by preparing antibodies with the desired paratope.
Haptens are chemicals that can bind to a region ofthe paratope of an antibody but cannot elicit an antibody response by themselves. Haptens usually have molecular weights less than 1000 (3). These small molecules can be coupled to larger molecules (carriers) to yield synthetic antigens. The elicited antibodies may recognize the hapten as part of the epitope.
Antibody Preparation
The process ofeliciting, purifying, and characterizing an antibody for an immunoassay is expensive and time consuming. When antigen binds to the membrane-bound antibody, the Blymphocyte is simulated to either divide into identical daughter cells or mature into a plasma cell that is capable ofsecreting antibody into the serum. The daughter cells follow the same pattern when an antigen binds to their surface antibody. The antibodies produced by a given B-lymphocyte and all its progeny possess identical paratopes and so are monoclonal. Antibodies from different B-lymphocyte parent cells are polyclonal.
Pblyclonal antibodies can be prepared quite easily by purifying the sera ofimmuniz aimals. This polyclonal sera contains many different antibodies including one or more with affinity for the desired analyte. Functionally, this is often not a problem since one paratope with a high affinity for the antigen will dominate the observed binding characteristics. Monoclonal antibodies offer the possibility of isolating a rare antibody in the polyclonal mixture that binds to a hapten with high affinity. Preparation of monoclonal antibodies is more involved than that ofpolyclonal antibodies. The B-lymphocytes are isolated from the spleen of an immunized animal. These mortal cells are then chemically fused with an immortal, established myeloma cell line. The resulting hybrid cells (hybridomas) retain the characteristics of producing antibody and immortality. The hybridomas are isolated as individual cells and grown in culture. All the daughter cells will produce monoclonal antibodies that may be isolated from the culture medium or from ascites fluid after injection of the hybridomas into a host animal.
After the antibodies are prepared, they can be used in a wide variety ofimmunoassa formats. Most schemes have the analytedirected antibody with a marker or a labeled second antibody that recognizes the analyte-directed antibody. The label or marker provides the basis for quantification.
Development of Immunoassays
There are four major stages in the development of an immunoassay: antibody production, antibody characterization, method validation, and final field studies. This entire process may take several months to years to complete. The requirements of the analyses should determine the need for making a monoclonal or polyclonal antibody. Production of antibodies was previously discussed.
Characterization includes evaluation ofthe specificity and affinity of the antibody. The class of the antibody should also be determined since polymeric immunoglobins (IgM) Once the antibody has been characterized fully, different formats of immunoassay should be tested for the best specificity, sensitivity, and reproducibility.
Methods validation for the immunoassay requires determination ofthe linear range for analyses, recovery studies using standards, and correlation with other chemical methods.
Use of Immunoassay to Detect Biomarkers
Several factors must be considered to determine if development or use ofan immunoassay is appropriate for a field study. The use of a specific antibody-based assay requires that the identity of the exposure agent(s) is known. Chemical analyses should be employed to measure weakly toxic agents that only require detection at high levels. Compounds that can be easily detected by more classical means rarely warrant immunoassay development unless a less expensive screening method is desired. An immunoassay should not be developed for an agent that will only be studied a few times due to the considerable cost of development.
There are several circumstances that are ideal for using immunoassays. Agents that are a major public health concern that will require repetitive studiesjustify the expense ofresources to develop the antibody. Agents that require low limits ofdetection that cannot be obtained by classical chemical (4, 5, 11) .
Several biological monitoring studies have been performed by various investigators using immunoassay for detecting biomarkers (Table 1. ) In these studies, biomarkers of exposure (urinary metabolites and macromolecular adducts) and biomarkers ofeffect (oncogene-related proteins) were all measured. An immunoassay capable of detecting aflatoxin B1 was used to compare the amounts found in the urine ofPhilippine and French residents (4). The Philippine residents had 13 times higher levels than the residents of France. This was probably due to higher levels of contamination in Philippine foodstuffs.
Sometimes it is more appropriate for the immunoassay to detect an important metabolite rather than the parent compound. The lipid-soluble pesticide is not readily excreted from the body. The major urinary metabolite ofDDT is the acetic acid derivative of the parent, DDA. An immunoassay was developed in India that can be perfomed on crude urine without extensive sample preparation (3).
Immunoassays have been used to detect proteins coded by oncogenes. The function ofthese protein products is not known, but their presence signals that the oncogenes have been activated. Oncogene activation is usually a result of retroviral infection, but some chemical carcinogens may also turn on these genes (6) . The oncogene-related proteins were found to be associated with smoking (7) .
A variation of immunoassay can be used to detect the immunologic response rather than a chemical antigen. The presence ofmacromolecule adducts can cause the body to mount an antibody response to the altered biomolecules. A high titer of antibodies to the altered biomolecules in the exposed person's serum is evidence of the formation of adducts.
Immunoassays to detect adduction in a wide variety of macromolecules have been successful. Antibodies that recognize benzo[a]pyrene-modified DNA have been found in coke oven workers (8) ; antibodies that recognize phthalic anhydridemodified albumin have been detected in chemical production workers (9) . Hospital workers that use ethylene oxide sterilization have been shown to have increased 2-hydroxyethyl-hemoglobin adduct levels when compared to other hospital employees (JO). Aflatoxin serum albumin adducts were found to correlate well with urinary metabolites in Chinese people that had a large dietary intake of aflatoxins from their corn consumption (11) . DNA adducts of N-nitrosamines and polycyclic aromatic hydrocarbons have been analyzed by immunoassays. Benzo[a]pyrene-DNA adducts were measured in the lymphocytes of roofers (12) , foundry (13) and coke oven workers (8) , firefighters (14) , smokers (15) , and following consumption of barbequed meat (14) .
Summary
Immunochemical analyses of biomarkers of exposure have been successfully developed by several investigators. Although there is great potential for use ofimmunoassays m such biological monitoring studies, the limitations ofthese methods must be fully understood to prevent improper evaluation ofthe acquired data. The differences between polyclonal and monoclonal antibodybased assays and the importance of antibody class, affinity, specificity, and cross-reactivity must be considered in the study design and the data analysis.
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